Practice Bulletin No. 141

Unknown author(s)

Obstetrics and Gynecology · 2013 · 421 citations · 81 references

Concepts

TL;DR

Vasomotor and vaginal symptoms are cardinal manifestations of menopause, affecting 50‑82 % of U.S. women and peaking about a year after the final menstrual period. This document aims to provide evidence‑based guidelines for treating vasomotor and vaginal symptoms associated with natural and surgical menopause. The guidelines are derived from a systematic review and synthesis of current evidence on therapeutic options for these menopausal symptoms.

Abstract

Vasomotor and vaginal symptoms are cardinal symptoms of menopause. Vasomotor symptoms can be particularly troubling to women and are the most commonly reported menopausal symptoms, with a reported prevalence of 50-82% among U.S. women who experience natural menopause (1, 2). The occurrence of vasomotor symptoms increases during the transition to menopause and peaks approximately 1 year after the final menstrual period (3-5). The purpose of this document is to provide evidence-based guidelines for the treatment of vasomotor and vaginal symptoms related to natural and surgical menopause. (Treatment of menopausal symptoms in cancer survivors is discussed in the American College of Obstetricians and Gynecologists' Practice Bulletin Number 126, Management of Gynecologic Issues in Women With Breast Cancer.).

References

81